Products and Services ／ Health Intelligence ／ Molecular Health Screening
MOLECULAR HEALTH / GENOMICS
Whole GenomeUnderstand your inherited background through genomics
Whole-genome and targeted genetic tests help you understand genetic background and health risks, and discuss suitable follow-up with a professional team.
Choose an appropriate plan with a professional team based on test focus, intended users, and individual needs.
01
Monogenic Variants + Polygenic Risk
WGS Precision Prevention Screening
Analyze whole-genome data to understand inherited background. Combine monogenic variant and polygenic risk assessments to discuss health management with a professional team.
Test Focus
Covers risk areas including cancer, cardiovascular disease, diabetes, autoimmune, neurological, digestive, and rare diseases. The actual report scope is limited by sequencing quality, analytical methods, databases, and the selected plan.
Who May Consider a Consultation
People interested in long-term health, genetic background, and familial risk.
Combines monogenic variant analysis, polygenic risk models, and professional recommendations to help explain hereditary cancer risk.
Test Focus
Comprehensive cancer genetic testing covers multiple cancer-related risk areas. Analytical content and suitability depend on the selected plan and professional assessment.
Who May Consider a Consultation
People concerned about hereditary cancer or family medical history who wish to consult a professional.
Understand your genetic background to build a foundation for long-term health management.
Whole Genome Sequencing (WGS) reads an individual's genome, including gene-coding and other regions. Sequencing and analysis search for health-related genetic variants among approximately 3 billion bases. The actual readable and interpretable scope still depends on sample quality, sequencing, and analytical methods.
DNAUnderstanding genetic background at the molecular level
01
Monogenic Variants
Examine variants in specific genes for information related to inherited diseases. Variant significance must be interpreted using professional guidelines, personal medical history, and family history.
02
Polygenic Risk
Combine multiple genetic variants to provide a reference for genetic risk in some common diseases. Model applicability may vary by population, disease, and available data.
03
Integrated Health Context
Combine age, family history, lifestyle, and other test results to help physicians and professional teams discuss appropriate health management.
YOUR SCREENING JOURNEY
From sampling to reporting, explore your genetic information step by step.
01Consultation and Assessment
Discuss personal and family health history, test scope, informed consent, and individual needs.
02Blood Sampling
A professional explains collection requirements and collects a blood sample.
03Sequencing and Analysis
Perform nucleic acid processing, whole-genome sequencing, and variant analysis. Quality and interpretable scope depend on the methods used.
04Report and Professional Interpretation
Discuss the report, the meaning of identified risks, and appropriate follow-up with a professional team.
UNDERSTANDING YOUR RESULTS
Interpret results in the context of your overall health.
Genetic risk is one part of a health assessment and does not determine whether you will or will not develop a disease. Finding no relevant variants does not exclude all genetic risks. Testing cannot replace established cancer screening, clinical examinations, or a physician's diagnosis. If you have a family history or specific concerns, discuss them with a physician or genetic counseling professional.
Prepare for Your Consultation
Personal medical history, current test results, and follow-up status
Family members' medical histories and ages at disease onset
Diseases or health issues of particular concern
Questions about test scope, data retention, and report interpretation
Report items, samples, turnaround time, data use, and fees are confirmed according to the selected plan and consent terms.
WGS / RISK AREAS
Health Areas Covered by Whole-genome Testing
The following are examples of risk-related areas listed in the plans. Specific items and interpretation depend on the test version, quality, and professional assessment.
Test items and counts depend on the plan, method, and services actually provided. Tests reflect specific risks or information at the time of sampling and cannot independently diagnose disease or replace physician assessment, routine screening, or treatment.
